Form EFFECT Eloxx Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 8, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In an Industry First, Dinari Launches 724 Tokenized Stocks Available to Both U.S. Investors and Businesses
- Ochsner ranked No.1 in Louisiana by U.S. News & World Report
- THIS NATIONAL DOG MONTH, WOOF AND AUTOCAMP ANNOUNCE NATIONWIDE PARTNERSHIP TO REDEFINE PET-FRIENDLY TRAVEL
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
